Gregor Makuc, Member of the Board of Management of Lek d.d.

Gregor Makuc graduated in Political Science, International Relations, from the Faculty of Social Sciences, University of Ljubljana, in 2001.

He acquired his professional experience first in the Protocol of the Republic of Slovenia and the Office of the Prime Minister between 2000 and 2004, and then as Secretary General of the International Forum on Pharmacy and Pharmaceutical Research from 2005 to 2011. From 2007 to 2011, he was a member of the Board of the Agency for Medicinal Products and Medical Devices, and since 2017 he has been a member of the Assembly of the Health Insurance Institute of Slovenia.

In 2011, he joined Novartis in Slovenia as Market Access Director for Novartis Innovative Medicines. He has been responsible for launching innovative medical products and managing public affairs projects in Central and Eastern Europe and the Baltic States. In 2014, he continued his career as a public and government affairs expert working on projects for Novartis.

In 2017, he was appointed Head of Public Affairs for Novartis in Slovenia. In this role, he supported Novartis Innovative Medicines, Lek d.d. and Sandoz d.d. in all matters related to public stakeholders. 

He was appointed Head of Communications and External Engagement on February 1, 2021, and Head Corporate Affairs in February 2023. 

As of July 4, 2023, Gregor Makuc has been appointed member of the Board of Management of Lek, where he is in charge of Corporate Affairs.